- AI for RNA biology and target discovery
- Built specifically for precision medicine teams, not bolt-on AI
- Scales to organization-wide healthcare rollouts
Deep Genomics
AI for RNA biology and targets
SF7.1
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Interpret genomic test results in contextRNA therapeutics research programs
Interpret genomic test results in contextRNA therapeutics research programs
Best for
RNA therapeutics research programs
Pricing
Custom
SoftFinders Score
7.1 / 10
Overview
What is Deep Genomics?
Deep Genomics is an AI genomics platform for RNA therapeutics teams, using machine learning to investigate RNA-targeted therapies and genetic disease biology.
- Clinical role: It supports genomic interpretation and precision care rather than standalone test results, so clinical context remains essential when genomic insights inform care decisions.
- Research fit: RNA therapeutics teams align best where AI for RNA biology and target discovery fits discovery programs.
- Implementation checks: Buyers should confirm test menu, turnaround time, EHR result delivery, clinical interpretation support, and workflow requirements before adoption across precision medicine and oncology services.
- Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, while engagement remains research and pipeline-led.
Deep Genomics is best assessed around RNA research fit, clinical interpretation, workflow integration, and support requirements.
KEY FEATURES
What you get out of the box
Genomic Interpretation
Interprets genomic test results in context
Multiomics Analysis
Analyzes multiple omics data layers together
Cancer Detection
Supports early cancer detection workflows
Biomarker Discovery
Tools to surface biomarker signals
Clinical Trials
Connects insights with clinical trial options
Precision Care
Supports precision care decisions across patients
USE CASES
Where teams put it to work
Interpret genomic test results in context
Support early cancer detection programs
Surface biomarker signals across data
Connect genomic insights with care decisions
Support precision oncology workflows
Bridge genomic data and clinical trials
Editorial Take
What we like, and what to verify
- Engagement is research and pipeline-led
- Clinical interpretation required for every result
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Verge Genomics SF 7.1
Why consider it
Human-data-first genomics drug discovery
Inflammatix SF 7.2
Why consider it
Gene-signature readouts for infection testing
Variantyx SF 7
Why consider it
Whole-genome analytics for clinical diagnosis
Genome Medical SF 7.1
Why consider it
Tech-enabled genetic counseling and testing network
Sully.ai SF 7.6
Why consider it
All-in-one AI scribe and clinician assistant
Tali AI SF 7.5
Why consider it
Voice AI scribe with built-in medical search
FAQ